Zobrazeno 1 - 10
of 570
pro vyhledávání: '"Grammas, P."'
Publikováno v:
Current Issues in Molecular Biology, Vol 43, Iss 1, Pp 215-225 (2021)
Mutations to the cholesterol transport protein apolipoprotein E (ApoE) have been identified as a major risk factor for the development of sporadic or late-onset Alzheimer’s disease (AD), with the e4 allele representing an increased risk and the rar
Externí odkaz:
https://doaj.org/article/1a2823261b964972accd80c50d1493a8
Autor:
Jaclyn Iannucci, Paula Grammas
Publikováno v:
Cells, Vol 12, Iss 9, p 1222 (2023)
Neurodegenerative diseases, including Alzheimer’s disease (AD), are major contributors to death and disability worldwide. A multitude of evidence suggests that neuroinflammation is critical in neurodegenerative disease processes. Exploring the key
Externí odkaz:
https://doaj.org/article/2d153eb7759349fe80fd05755511c708
Publikováno v:
Cerebral Circulation - Cognition and Behavior, Vol 2, Iss , Pp 100014- (2021)
Background: Vascular risk factors such as atherosclerosis, diabetes, and elevated homocysteine levels are strongly correlated with onset of Alzheimer's disease (AD). Emerging evidence indicates that blood coagulation protein thrombin is associated wi
Externí odkaz:
https://doaj.org/article/c2c83101daef4c86bf2e9b6a1b98fcd5
Autor:
Jaclyn Iannucci, Shelby L. Johnson, Mark Majchrzak, Benjamin J. Barlock, Fatemeh Akhlaghi, Navindra P. Seeram, Abhik Sen, Paula Grammas
Publikováno v:
Biochemistry and Biophysics Reports, Vol 24, Iss , Pp 100862- (2020)
Proteins that regulate the coagulation cascade, including thrombin, are elevated in the brains of Alzheimer's disease (AD) patients. While studies using amyloid-based AD transgenic mouse models have implicated thrombin as a protein of interest, the r
Externí odkaz:
https://doaj.org/article/03ac6d10deab459f80d89734a98f9d4e
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
The societal burden of Alzheimer’s disease (AD) is staggering, with current estimates suggesting that 50 million people world-wide have AD. Identification of new therapeutic targets is a critical barrier to the development of disease-modifying ther
Externí odkaz:
https://doaj.org/article/d39585a673324588b103198c5643ff1e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Brian R. Ott, Richard N. Jones, Lori A. Daiello, Suzanne M. de la Monte, Edward G. Stopa, Conrad E. Johanson, Charles Denby, Paula Grammas
Publikováno v:
Frontiers in Aging Neuroscience, Vol 10 (2018)
Background: The pathophysiology underlying altered blood-cerebrospinal fluid barrier (BCSFB) function in Alzheimer's disease (AD) is unknown but may relate to endothelial cell activation and cytokine mediated inflammation.Methods: Cerebrospinal fluid
Externí odkaz:
https://doaj.org/article/89cdffa1cdd74c17b913398e9c3a9283
Publikováno v:
In Microvascular Research March 2012 83(2):138-145
Publikováno v:
In Neuroscience Research 2012 72(1):1-8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.